Related Experiment Video

Updated: Oct 1, 2026

High-Efficiency Transduction of Liver Cancer Cells by Recombinant Adeno-Associated Virus Serotype 3 Vectors
19:02

High-Efficiency Transduction of Liver Cancer Cells by Recombinant Adeno-Associated Virus Serotype 3 Vectors

Published on: March 22, 2011

Sensitization of sarcoma cells to doxorubicin treatment by concomitant wild-type adeno-associated virus type 2

Matthias H M Schwarzbach1, Sven Eisold, Tatiana Burguete

  • 1Department of Surgery, University of Heidelberg, INF 110, Germany.

International Journal of Oncology
|May 16, 2002
PubMed

Insights

Adeno-associated virus type 2 (AAV-2) infection enhances doxorubicin chemotherapy efficacy in specific sarcoma types. This viral therapy improves treatment outcomes for rhabdomyosarcoma, fibrosarcoma, osteosarcoma, and chondrosarcoma.

Area of Science:

  • Oncology
  • Virology
  • Genetics

Background:

  • Doxorubicin chemotherapy is a standard treatment for sarcomas but suffers from toxic side effects and limited efficacy.
  • There is a need for improved chemotherapeutic strategies to enhance treatment outcomes for sarcoma patients.
  • Parvoviruses, including adeno-associated virus type 2 (AAV-2), have demonstrated antineoplastic properties and can sensitize cells to genotoxic treatments.

Purpose of the Study:

  • To investigate whether adeno-associated virus type 2 (AAV-2) infection can improve the efficacy of doxorubicin chemotherapy in human sarcoma cell lines.
  • To determine the specific sarcoma subtypes that benefit from AAV-2 mediated sensitization to doxorubicin.
  • To assess the correlation between AAV-2 infection permissivity and enhanced chemotherapy response.

Main Methods:

  • Utilized 13 human sarcoma cell lines for in vitro analysis.
  • Assessed therapeutic effects using cell viability and proliferation assays (WST-1, colony forming, propidium iodide).
  • Determined AAV-2 infection permissivity via Southern dot blot analysis.

Main Results:

  • AAV-2 infection significantly enhanced doxorubicin efficacy in rhabdomyosarcoma, fibrosarcoma, osteosarcoma, and chondrosarcoma cells in a dose-dependent manner.
  • The sensitizing effect of AAV-2 was not observed in liposarcoma and synovial sarcoma cells, despite documented susceptibility to infection.
  • These findings suggest that AAV-2 mediated sensitization is sarcoma subtype-specific.

Conclusions:

  • Non-pathogenic AAV-2 infection can sensitize malignant mesenchymal cells to genotoxic chemotherapy, extending beyond epithelial malignancies.
  • AAV-2 holds potential for improving doxorubicin chemotherapy outcomes in patients with specific sarcoma types, including rhabdomyosarcoma, fibrosarcoma, osteosarcoma, and chondrosarcoma.
  • Further research may explore AAV-2 as an adjunct therapy to overcome chemoresistance in certain sarcomas.

More Related Videos

Transgene Expression in Cultured Cells Using Unpurified Recombinant Adeno-Associated Viral Vectors06:41

Transgene Expression in Cultured Cells Using Unpurified Recombinant Adeno-Associated Viral Vectors

Published on: October 20, 2023

Related Concept Videos

Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...